Publications by authors named "Torsten Diesinger"

Claim this Profile
A
A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma.
Torsten Diesinger, Alfred Lautwein, Sebastian Bergler, Dominik Buckert, Christian Renz

Can J Gastroenterol Hepatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Ï
ω-Imidazolyl-alkyl derivatives as new preclinical drug candidates for treating non-alcoholic steatohepatitis.
Torsten Diesinger, Alfred Lautwein, Vyacheslav Buko, Elena Belonovskaya, Oksana Lukivskaya

Physiol Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug targeting CYP2E1 for the treatment of early-stage alcoholic steatohepatitis.
Torsten Diesinger, Vyacheslav Buko, Alfred Lautwein, Radovan Dvorsky, Elena Belonovskaya

PLoS One· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of cytochrome P450 mediated enzyme activity by alkylphosphocholines.
Thomas Haehner, Ulrich Massing, Torsten Diesinger, Dieter Müller-Enoch

Z Naturforsch C J Biosci· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis